← Eichor
Condition: Low Grade Glioma Of Brain Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Low Grade Glioma Of Brain

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma
NA · 1 location(s) · University of California, San Francisco · NCT07506239Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
EARLY_Phase 1 · 1 location(s) · Children's Hospital of Philadelphia · NCT05555550Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy
Phase 2/Phase 3 · 1 location(s) · Chang Gung Memorial Hospital · NCT03534050A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain Tumours
Phase 1 · 6 location(s) · Ipsen · NCT07441707ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
Phase 1 · 1 location(s) · Katy Peters, MD, PhD · NCT05609994SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Phase 1/Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT04923126Measure of the Potential Evoked by Electric Stimulation
NA · 1 location(s) · University Hospital, Montpellier · NCT02509442Longitudinal Analysis of the Health-related Quality of Life in Glioma Patients
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT03849430A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced So
Phase 1 · 83 location(s) · Pfizer · NCT05538130Patient Voice in the Treatment of Low-grade Gliomas: Use of Patient-reported Outcomes, Vorasidenib and Radiotherapy Comp
Phase N/A · 1 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT07547163Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
Phase 2 · 7 location(s) · University of California, San Francisco · NCT07110246Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker
Phase 2 · 1 location(s) · David W. Roberts · NCT02691923Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
Phase 2 · 1 location(s) · Emory University · NCT06132685Window of Opportunity Study of DSP-0390 in Gliomas
EARLY_Phase 1 · 1 location(s) · Washington University School of Medicine · NCT06636162
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.